New pages
Jump to navigation
Jump to search
28 October 2026
- 20:3220:32, 28 October 2026 Neuromyelitis optica spectrum disorder CT (hist | edit) [4,232 bytes] Julinka Auta Fernandes (talk | contribs) (Created page with "__NOTOC__ {{Neuromyelitis optica spectrum disorder}} {{CMG}} {{AE}} {{JAF}} ==Overview== Computed tomography (CT) is not included as a diagnostic imaging criterion for neuromyelitis optica spectrum disorder (NMOSD) in the cited recommendations. The recommended neurological imaging assessment uses magnetic resonance imaging (MRI) of the brain and spinal cord.<ref name="NEMOS2023">{{cite journal |vauthors=Jarius S, Aktas O, Ayzenberg I |display-authors=etal |title=Upda...")
- 20:0520:05, 28 October 2026 Neuromyelitis optica spectrum disorder chest x ray (hist | edit) [3,090 bytes] Julinka Auta Fernandes (talk | contribs) (Created page with "__NOTOC__ {{Neuromyelitis optica spectrum disorder}} {{CMG}} {{AE}} {{JAF}} ==Overview== Chest X-ray findings are not included in the international consensus diagnostic criteria for neuromyelitis optica spectrum disorder (NMOSD). Accordingly, chest X-ray alone cannot confirm or exclude NMOSD.<ref name="IPND2015">{{cite journal |vauthors=Wingerchuk DM, Banwell B, Bennett JL |display-authors=etal |title=International consensus diagnostic criteria for neuromyelitis opti...")
27 October 2026
- 19:1319:13, 27 October 2026 Neuromyelitis optica spectrum disorder electrocardiogram (hist | edit) [2,783 bytes] Julinka Auta Fernandes (talk | contribs) (Created page with "__NOTOC__ {{Neuromyelitis optica spectrum disorder}} {{CMG}} {{AE}} {{JAF}} ==Overview== For neuromyelitis optica spectrum disorder (NMOSD), an electrocardiogram (ECG) is not included in the international consensus diagnostic criteria. Consequently, ECG alone cannot confirm or exclude NMOSD.<ref name="IPND2015">Wingerchuk DM, Banwell B, Bennett JL, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. ''Neurology''. 2015;85(2):1...")
- 13:1213:12, 27 October 2026 Neuromyelitis optica spectrum disorder laboratory findings (hist | edit) [9,997 bytes] Julinka Auta Fernandes (talk | contribs) (Created page with "__NOTOC__ {{Neuromyelitis optica spectrum disorder}} {{CMG}} {{AE}} {{JAF}} ==Overview== * Laboratory findings consistent with neuromyelitis optica spectrum disorder (NMOSD) include serum aquaporin-4 immunoglobulin G (AQP4-IgG) positivity and, in some patients, cerebrospinal fluid (CSF) inflammation. AQP4-IgG is the principal disease-associated laboratory marker; positivity must be interpreted with a compatible clinical syndrome and exclusion of alternative diagnose...")
23 October 2026
- 22:2822:28, 23 October 2026 Neuromyelitis optica spectrum disorder physical examination (hist | edit) [8,647 bytes] Julinka Auta Fernandes (talk | contribs) (Created page with "__NOTOC__ {{Neuromyelitis optica spectrum disorder}} {{CMG}} {{AE}} {{JAF}} ==Overview== * Neuromyelitis optica spectrum disorder (NMOSD) has no single pathognomonic physical examination finding. The examination is used to identify, localize, and document objective deficits caused by optic nerve, spinal cord, brainstem, diencephalic, or cerebral involvement.<ref name="IPND2015">Wingerchuk DM, Banwell B, Bennett JL, et al. [https://pubmed.ncbi.nlm.nih.gov/26092914/ I...")
- 20:1020:10, 23 October 2026 Neuromyelitis optica spectrum disorder history and symptoms (hist | edit) [7,712 bytes] Julinka Auta Fernandes (talk | contribs) (Created page with "__NOTOC__ {{Neuromyelitis optica spectrum disorder}} {{CMG}} {{AE}} {{JAF}} ==Overview== * Neuromyelitis optica spectrum disorder (NMOSD) usually presents with acute or subacute attacks involving the optic nerves, spinal cord, area postrema, brainstem, diencephalon, or cerebrum. The two clinical hallmarks are optic neuritis and acute myelitis; they may occur simultaneously but more often occur successively.<ref name="NEMOS2023">Jarius S, Aktas O, Ayzenberg I...")
21 October 2026
- 14:2314:23, 21 October 2026 Neuromyelitis optica spectrum disorder diagnostic study of choice (hist | edit) [15,800 bytes] Julinka Auta Fernandes (talk | contribs) (Created page with "__NOTOC__ {{Neuromyelitis optica spectrum disorder}} {{CMG}} {{AE}} {{JAF}} '''For the WikiDoc physician page on this topic, click here.''' ==Overview== * '''Neuromyelitis optica spectrum disorder''' (NMOSD) is a rare autoimmune disease in which the immune system mistakenly causes inflammation in the central nervous system, especially the nerves that carry vision from the eyes to the brain (the optic nerves), the spinal cord,...")
20 October 2026
- 20:4820:48, 20 October 2026 Sandbox:MSA (hist | edit) [0 bytes] Dr Muhammad Saad (talk | contribs) (Created blank page)
- 14:2014:20, 20 October 2026 Neuromyelitis optica spectrum disorder (patient information) (hist | edit) [19,561 bytes] Julinka Auta Fernandes (talk | contribs) (Created page with "__NOTOC__ {{Neuromyelitis optica spectrum disorder}} {{CMG}} {{AE}} {{JAF}} '''For the WikiDoc physician page on this topic, click here.''' ==Overview== * '''Neuromyelitis optica spectrum disorder''' (NMOSD) is a rare autoimmune disease in which the immune system mistakenly causes inflammation in the central nervous system, especially the nerves that carry vision from the eyes to the brain (the optic nerves), the spinal cord,...")
19 October 2026
- 17:3917:39, 19 October 2026 Neuromyelitis optica spectrum disorder natural history, complications and prognosis (hist | edit) [18,050 bytes] Julinka Auta Fernandes (talk | contribs) (Created page with "__NOTOC__ {{Neuromyelitis optica spectrum disorder}} {{CMG}} {{AE}} {{JAF}} ==Overview== * Neuromyelitis optica spectrum disorder (NMOSD) usually follows a relapsing course characterized by acute attacks of optic neuritis, myelitis, area postrema syndrome, or other brainstem, diencephalic, or cerebral syndromes. In aquaporin-4 immunoglobulin G (AQP4-IgG)-positive NMOSD, the risk of relapse persists indefinitely; a mon...")
- 17:2017:20, 19 October 2026 Neuromyelitis optica spectrum disorder screening (hist | edit) [11,276 bytes] Julinka Auta Fernandes (talk | contribs) (Created page with "__NOTOC__ {{Neuromyelitis optica spectrum disorder}} {{CMG}} {{AE}} {{JAF}} ==Overview== * There is insufficient evidence to recommend routine screening for neuromyelitis optica spectrum disorder (NMOSD) in asymptomatic individuals. Current recommendations from the Neuromyelitis Optica Study Group (NEMOS) and the Middle East and North Africa Committee for Treatment and Research in Multiple Sclerosis (MENACTRIMS) do not establish a population-screening program, scree...")
- 16:4216:42, 19 October 2026 Neuromyelitis optica spectrum disorder risk factors (hist | edit) [11,310 bytes] Julinka Auta Fernandes (talk | contribs) (Created page with "__NOTOC__ {{Neuromyelitis optica spectrum disorder}} {{CMG}} {{AE}} {{JAF}} ==Overview== * Risk factors for developing neuromyelitis optica spectrum disorder (NMOSD) remain incompletely established. The most reproducible associations are female sex, higher population-level occurrence among people of Black/African ancestry and in some East Asian populations, selected immunogenetic variants, and coexisting autoimmune disease.<ref name="NEMOS2023">Jarius S, Aktas O...")
- 14:4414:44, 19 October 2026 Neuromyelitis optica spectrum disorder epidemiology and demographics (hist | edit) [10,846 bytes] Julinka Auta Fernandes (talk | contribs) (Created page with "__NOTOC__ {{Neuromyelitis optica spectrum disorder}} {{CMG}} {{AE}} {{JAF}} ==Overview== * Neuromyelitis optica spectrum disorder (NMOSD) is a rare disease reported worldwide. A 2026 systematic review and meta-analysis of 44 studies from 28 countries found a pooled prevalence of '''2.02 per 100,000 persons'''; individual study estimates ranged from '''0.23 to 10 per 100,000 persons'''.<ref name="Alvarenga2026">{{cite journal |author=Alvarenga RMP, Namen ME, Alva...")
- 14:0514:05, 19 October 2026 Neuromyelitis optica spectrum disorder differential diagnosis (hist | edit) [20,515 bytes] Julinka Auta Fernandes (talk | contribs) (Created page with "__NOTOC__ {{Neuromyelitis optica spectrum disorder}} {{CMG}} {{AE}} {{JAF}} ==Overview== * Neuromyelitis optica spectrum disorder (NMOSD) must be differentiated from other disorders that can cause optic neuritis, acute myelitis, longitudinally extensive transverse myelitis, area postrema syndrome, brainstem syndromes, or inflammatory-appearing lesions of the brain and spinal cord. * The most important inflammatory differential diagnoses are myelin o...")
- 12:4512:45, 19 October 2026 Neuromyelitis optica spectrum disorder causes (hist | edit) [8,589 bytes] Julinka Auta Fernandes (talk | contribs) (Created page with "__NOTOC__ {{Neuromyelitis optica spectrum disorder}} {{CMG}} {{AE}} {{JAF}} ==Overview== Neuromyelitis optica spectrum disorder (NMOSD) is an acquired autoimmune disease of the central nervous system, but its initiating cause has not been identified. Most patients have pathogenic aquaporin-4 immunoglobulin G (AQP4-IgG); this autoantibody is an established disease-driving mediator, but its presence does not explain why immune tolerance...")
17 October 2026
- 14:3714:37, 17 October 2026 Neuromyelitis optica spectrum disorder pathophysiology (hist | edit) [21,989 bytes] Julinka Auta Fernandes (talk | contribs) (Created page with "__NOTOC__ {{Neuromyelitis optica spectrum disorder}} {{CMG}} {{AE}} {{JAF}} ==Overview== * Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune inflammatory disorder of the central nervous system (CNS). In aquaporin-4 immunoglobulin G-positive disease, NMOSD is primarily an antibody-mediated astrocytopathy rather than a primary disorder of myelin.<ref name="Primer2020">Jarius S, Paul F, Weinshenker BG, et al. [https://pubmed.ncbi.nlm...")
- 14:0014:00, 17 October 2026 Neuromyelitis optica spectrum disorder classification (hist | edit) [8,559 bytes] Julinka Auta Fernandes (talk | contribs) (Created page with "__NOTOC__ {{Neuromyelitis optica spectrum disorder}} {{CMG}} {{AE}} {{JAF}} ==Overview== * Neuromyelitis optica spectrum disorder (NMOSD) is classified primarily according to serum aquaporin-4 immunoglobulin G (AQP4-IgG) serostatus and may additionally be described according to its clinical course. * The 2015 International Panel for Neuromyelitis Optica Diagnosis (IPND) consensus framework defines two formal serologic categories: '''NMOSD with AQP4-I...")